THE EFFICACY OF FOURTEEN-DAYS ESOMEPRAZOLE AND AMOXICILLIN CONTAINING HIGH DOSE DUAL THERAPY IN THE TREATMENT OF FIRST-LINE ANTI-H. PYLORI THERAPY: A PROSPECTIVE RANDOMIZED TRIAL

被引：0
|
作者：
Huang, Pao-Yuan
Ma, Te-Ling
Tai, Wei-Chen
Liang, Chih-Ming
Wu, Keng-Liang
Chuah, Seng-Kee
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
436
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] 14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Fang, Yu-Jen
    Chen, Po-Yueh
    Chang, Chi-Yang
    Chou, Chu-Kuang
    Chen, Mei-Jyh
    Tseng, Cheng-Hao
    Lee, Ji-Yuh
    Yang, Tsung-Hua
    Chiu, Min-Chin
    Yu, Jian-Jyun
    Kuo, Chia-Chi
    Luo, Jiing-Chyuan
    Hsu, Wen-Feng
    Hu, Wen-Hao
    Tsai, Min-Horn
    Lin, Jaw-Town
    Shun, Chia-Tung
    Twu, Gary
    Lee, Yi-Chia
    Bair, Ming-Jong
    Wu, Ming-Shiang
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2510 - 2518
  • [22] Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori
    Yang, Jing
    Zhang, Yi
    Fan, Ling
    Zhu, Yang-Jie
    Wang, Ting-Yi
    Wang, Xing-Wei
    Chen, Dong-Feng
    Lan, Chun-Hui
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 437 - 445
  • [23] EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY WITH PPI-AMOXICILLIN FOR FIRST-LINE HELICOBACTER PYLORI IN CHILE: EXPERIENCE FROM A PROSPECTIVE STUDY
    von Muhlenbrock, Christian
    Quera, Rodrigo
    Cordova, Andrea
    Nunez, Paulina
    GASTROENTEROLOGY, 2023, 164 (06) : S378 - S379
  • [24] Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial
    Xiao-Dong Zhang
    Da-Ya Zhang
    Run-Xiang Chen
    Shi-Ju Chen
    Chen Chen
    Fan Zeng
    Shi-Mei Huang
    Da Li
    Fei-Hu Bai
    BMC Gastroenterology, 23
  • [25] Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial
    Zhang, Xiao-Dong
    Zhang, Da-Ya
    Chen, Run-Xiang
    Chen, Shi-Ju
    Chen, Chen
    Zeng, Fan
    Huang, Shi-Mei
    Li, Da
    Bai, Fei-Hu
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [26] Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
    Suzuki, Sho
    Gotoda, Takuji
    Kusano, Chika
    Ikehara, Hisatomo
    Ichijima, Ryoji
    Ohyauchi, Motoki
    Ito, Hirotaka
    Kawamura, Masashi
    Ogata, Yohei
    Ohtaka, Masahiko
    Nakahara, Moriyasu
    Kawabe, Koichi
    GUT, 2020, 69 (06) : 1019 - +
  • [27] Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
    Bang, Chang Seok
    Lim, Hyun
    Jeong, Hae Min
    Shin, Woon Geon
    Choi, Jae Ho
    Soh, Jae Seung
    Kang, Ho Suk
    Yang, Young Joo
    Hong, Ji Taek
    Shin, Suk Pyo
    Suk, Ki Tae
    Lee, Jae Jun
    Baik, Gwang Ho
    Kim, Dong Joon
    GUT MICROBES, 2020, 11 (05) : 1314 - 1323
  • [28] Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial
    Cheng, Jianping
    Fan, Chanjuan
    Huang, Kun
    Zhai, Lili
    Wang, Hui
    Xie, Dongling
    Cai, Yong
    Li, Zhen
    Bai, Qixuan
    Wang, Pan
    Ding, Haiou
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, A.
    Kadayifci, A.
    Safali, M.
    Ilgan, S.
    Bagci, S.
    HELICOBACTER, 2007, 12 (04) : 430 - 430
  • [30] The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori
    Uygun, Ahmet
    Kadayifci, Abdurrahman
    Safali, Mukerrem
    Ilgan, Seyfettin
    Bagci, Sait
    JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (04) : 211 - 215
12345